Nektar Therapeutics
IMMUNOTHERAPEUTIC TUMOR TREATMENT METHOD USING AN INTERLEUKIN-2 RECEPTOR ALPHA, BETA-SELECTIVE AGONIST IN COMBINATION WITH ADOPTIVE CELL TRANSFER THERAPY

Abstract:

Provided are methods and compositions directed towards the treatment of an individual having cancer by providing adoptive cell transfer therapy and administering to the individual a long acting IL-2R.alpha..beta.-biased agonist.